Funding
 |  |
 |  |
 |  |
 |  |
 |  |
CIHR
2020/4 – 2025/3
Protein phase separation: a new mechanism of protein function regulation in Mycobacterium tuberculosis
With Joerg Gsponer and Lawrence mcKintosh
CIHR Project Grant – $789,000 CAD
2021/4 – 2026/3
Principal Applicant
Host- directed therapies in Tuberculosis – Operating Grant
Canadian Institutes of Health Research (CIHR)
Project Grant Priority Announcement, Total Funding – $750,000
2017/7 – 2022/6
Host-pathogen directed therapies in Tuberculosis
CIHR Project Grant – $1,009,800 CAD
Press Release
2016/7 – 2021/6:
Intracellular growth of Mycobacterium tuberculosis: Prospects for drug discovery – Operating Grant
CIHR Project Grant – $802,725 CAD
Press Release
2010/9 – 2015/8
Molecular analysis of Mycobacterium tuberculosis Signalling – Operating Grant
CIHR Operating Grant – $750,000 CAD
2008/4 – 2013/3
Mycobacterial Cholesterol metabolism: A key piece in the pathogenesis puzzle (PI Dr. William Mohn)
CIHR Operating Grant – $540,000 CAD
2009/9 – 2012/12
High-throughput screening and identification of anti-TB compounds from a unique natural product library
CIHR China-Canada Joint Health Research Initiative – $150,000 CAD
2009/9 – 2010/8
Molecular analysis of Mycobacterium Tuberculosis Protein Kinsases and Phosphatases – Operating Grant
CIHR Operating Grant Bridge Funding – $100,000
2004/10 – 2009/9
Molecular analysis of Mycobacterium tuberculosis Protein Kinases and Phosphatases – Operating Grant
CIHR Operating Grant Renewal – $575,490
2006/12 – 2008/12
Chemical genetics of intrinsic antibiotic resistance and virulence determinants in Mycobacterium tuberculosis – Infrastructure Grant
CIHR Novel Alternatives to Antibiotics Research Initiative – $149,300
2003/4 – 2008/3
UBC training program for translational research in Infectious Diseases – Team Grant
CIHR Strategic Training Programs grants – $1,697,250
2001/4 – 2004/3
Molecular Analysis of Mycobacterium tuberculosis protein kinases and phosphatases – Operating Grant
CIHR Operating Grants – $230,000
Cystic Fibrosis Canada
2017/4 – 2020/3
Targeting Intracellular and biofilm associated Mycobacterium abscessus for drug discovery – Operating Grant
Cystic Fibrosis Canada – $279,050 CAD
2022/4 – 2025/3
Hit to lead: Novel anti Mycobacterium abscessus agents – Operating Grant
Cystic Fibrosis Canada – $300,000 CAD
British Columbia Lung Association
2022/12 – 2023/11
Host cell signalling targeted COVID-19 therapy
British Columbia Lung Association – $30,000 CAD
2020/10 – 2022/9
Targeting mycobacterial-host signaling for TB drug development
British Columbia Lung Association – $50,000 CAD
2015/10 – 2017/9
Intracellular growth of Mycobacterium tuberculosis: prospects for drug discovery – Operating Grants
British Columbia Lung Association – $50,000 CAD
2013/10 – 2015/9
Role of Ergothioneine in the Physiology of Mycobacterium tuberculosis – Operating Grant
British Columbia Lung Association – $60,000 CAD
2009/10 – 2011/9
Protein Phosphatase A signaling in Mycobacterium tuberculosis pathogenesis – Operating Grant
British Columbia Lung Association – $60,000 CAD
2007/10 – 2009/9
Mycobacterium tuberculosis Protein Kinase J; Role in infection and antibiotic resistance – Operating Grant
British Columbia Lung Association – $45,000
Michael Smith Foundation for Health Research (Team grants)
2007/7 – 2009/6
Development of novel TB therapeutics, Mycobacteria Research Group
Michael Smith Foundation for Health Research – $150,000
2003/10 – 2009/9
Immunity and Infection Research Centre – Infrastructure Grant
Michael Smith Foundation for Health Research – $150,000
The European Commission
2016/3 – 2018/5
Intra-macrophage driven optimization of confirmed hit GSK421197A – Grant
The European Commission, FP7 – $220,000 CAD
TB Veteran Association
2022/1 – 2026/1
Dr. Av-Gay research lab support from TB Vets – Operating Grant
TB Veterans Association – $50,000 CAD/ year
2017/9 – 2021/8
TB Vets 2017 Frontline Heroes Grant Award: – Operating Grant
TB Veterans Association – $45,000 CAD/ year
2012/9 – 2017/8
TB Vets Award: General support for TB Research – Operating Grant
TB Veterans Association – $250,000 CAD
2006/9 – 2011/8
TB Vets Award: General support for TB Research – Operating Grant
TB Veterans Association – $300,000 CAD
1997/9 – 2006/8
TB Vets Award: Establishment and operation of BCL-3 Facility- Infrastructure and equipment grant
TB Veterans Association – $450,000 CAD
GlaxoSmithKline (Tres Cantos) Open Lab
2013/1 – 2015/12
High Throughput Screening for New Small Molecules to eliminate Mycobacterium tuberculosis inside infected Human Macrophages – Operating Grant
GlaxoSmithKline Open Lab – $260,000 CAD
2016/3 – 2018/5
Intra-macrophage driven optimization of confirmed hits – Grant
Funding by The European Commission, FP7 – $220,000 CAD
Mathematics of Information Technology and Complex Systems
2015/11 – 2017/10
Matching funds to BC Lung – Intracellular growth of Mycobacterium tuberculosis: prospects for drug discovery – Grant
Mathematics of Information Technology and Complex Systems (MITACS) – $90,000 CAD
The Defence Advanced Research Project Agency (co-applicant)
2010/7 – 2012/8
Nitric Oxide for Prevention and Treatment of Pandemic Flu
The Defense Advanced Research Project Agency – $361,000 CAD
Lotte & John Hecht Memorial Foundation
2008/4 – 2013/3
Development of Nitric Oxide delivery device for treatment of pandemic flu
Lotte & John Hecht Memorial Foundation – $520,000 CAD
A&J Sciences Korea.
2023/2 – 2023/12
Screening of Novel Anti-microbial Formulations for Activity in vitro (Macrophage Infection Model)
Contract: $65,495.99 CAD
Angal Bio.
2021/2 – 2022/1
Chinese Medicines Against Intracellular TB
Contract: $69,481.67 CAD
AIT Therapeutics Inc.
2013/9 – 2015/8
Nitric Oxide Inhalation Therapies
Partnership: AIT Therapeutics . – $200,000 CAD
Enox Biopharma Inc.
2007/9 – 2012/8
Nitric Oxide Coated Medical Devises
Partnership: Enox Biopharma Inc. – $220,000 CAD